Int. J. Mol. Sci. 2014, 15(1), 895-904; doi:10.3390/ijms15010895

Luteolin Reduces Alzheimer’s Disease Pathologies Induced by Traumatic Brain Injury

1,2,* email, 2,3email, 4email, 4email, 1,2email, 2email, 4email, 4email and 1,2email
Received: 29 October 2013; in revised form: 3 January 2014 / Accepted: 6 January 2014 / Published: 9 January 2014
(This article belongs to the Special Issue Pathology and Treatment of Central Nervous System Diseases)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Traumatic brain injury (TBI) occurs in response to an acute insult to the head and is recognized as a major risk factor for Alzheimer’s disease (AD). Indeed, recent studies have suggested a pathological overlap between TBI and AD, with both conditions exhibiting amyloid-beta (Aβ) deposits, tauopathy, and neuroinflammation. Additional studies involving animal models of AD indicate that some AD-related genotypic determinants may be critical factors enhancing temporal and phenotypic symptoms of TBI. Thus in the present study, we examined sub-acute effects of moderate TBI delivered by a gas-driven shock tube device in Aβ depositing Tg2576 mice. Three days later, significant increases in b-amyloid deposition, glycogen synthase-3 (GSK-3) activation, phospho-tau, and pro-inflammatory cytokines were observed. Importantly, peripheral treatment with the naturally occurring flavonoid, luteolin, significantly abolished these accelerated pathologies. This study lays the groundwork for a safe and natural compound that could prevent or treat TBI with minimal or no deleterious side effects in combat personnel and others at risk or who have experienced TBI.
Keywords: traumatic brain injury; Alzheimer’s disease; amyloidogenesis; tauopathy; GSK; neuroinflammation; luteolin
PDF Full-text Download PDF Full-Text [357 KB, uploaded 19 June 2014 05:23 CEST]

Export to BibTeX |

MDPI and ACS Style

Sawmiller, D.; Li, S.; Shahaduzzaman, M.; Smith, A.J.; Obregon, D.; Giunta, B.; Borlongan, C.V.; Sanberg, P.R.; Tan, J. Luteolin Reduces Alzheimer’s Disease Pathologies Induced by Traumatic Brain Injury. Int. J. Mol. Sci. 2014, 15, 895-904.

AMA Style

Sawmiller D, Li S, Shahaduzzaman M, Smith AJ, Obregon D, Giunta B, Borlongan CV, Sanberg PR, Tan J. Luteolin Reduces Alzheimer’s Disease Pathologies Induced by Traumatic Brain Injury. International Journal of Molecular Sciences. 2014; 15(1):895-904.

Chicago/Turabian Style

Sawmiller, Darrell; Li, Song; Shahaduzzaman, Md; Smith, Adam J.; Obregon, Demian; Giunta, Brian; Borlongan, Cesar V.; Sanberg, Paul R.; Tan, Jun. 2014. "Luteolin Reduces Alzheimer’s Disease Pathologies Induced by Traumatic Brain Injury." Int. J. Mol. Sci. 15, no. 1: 895-904.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert